RNA sequencing services market

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4 Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. An Overview of RNA Sequencing
3.2.1. Key Steps Involved in RNA Sequencing
3.2.2. Types of RNA Sequencing
3.2.2.1. Single End Sequencing
3.2.2.2. Paired End Sequencing

3.2.3. Methods of RNA Sequencing
3.2.3.1. First Generation Sequencing
3.2.3.2. Next Generation Sequencing
3.2.3.3. Third Generation Sequencing

3.2.4. Applications of RNA Sequencing
3.2.5. Advantages of RNA Sequencing
3.2.6. Limitations of RNA Sequencing

3.2.7. RNA Sequencing Platforms
3.2.7.1. Illumina Sequencing Platforms
3.2.7.2. Pac Bio Sequencing Platforms
3.2.7.3. Nanopore Sequencing Platforms

3.3. Concluding Remarks

4. RNA SEQUENCING SERVICE PROVIDERS: MARKET OVERVIEW
4.1. Chapter Overview
4.1.1. RNA Sequencing Service Providers
4.1.2. Analysis by Year of Establishment
4.1.3. Analysis by Company Size
4.1.4. Analysis by Location of Headquarters
4.1.5. Analysis by Company Size and Region of Headquarters
4.1.6. Analysis by Type of RNA Sequencing Service(s)
4.1.7. Analysis by Type of Platform
4.1.8. Analysis by Turnaround Time
4.1.9. Analysis by Type of Sample
4.1.10. Analysis by Amount of Sample

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Scope and Methodology
5.4. Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
5.5. Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
5.6. Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific and Rest of the World

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Admera Health
6.2.1. Company Overview
6.2.2. RNA Sequencing Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Biogazelle (acquired by CellCarta)
6.3.1. Company Overview
6.3.2. RNA Sequencing Service Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. CD Genomics
6.4.1. Company Overview
6.4.2. RNA Sequencing Service Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Creative Biogene
6.5.1. Company Overview
6.5.2. RNA Sequencing Service Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. IGA Technology
6.6.1. Company Overview
6.6.2. RNA Sequencing Service Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. LC Sciences
6.7.1. Company Overview
6.7.2. RNA Sequencing Service Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Lexogen
6.8.1. Company Overview
6.8.2. RNA Sequencing Service Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. Novogene
6.9.1. Company Overview
6.9.2. RNA Sequencing Service Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Otogenetics
6.10.1. Company Overview
6.10.2. RNA Sequencing Service Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. Yaazh Xenomic
6.11.1. Company Overview
6.11.2. RNA Sequencing Service Portfolio
6.11.3. Recent Developments and Future Outlook

7. ACADEMIC GRANT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Analysis by Year of Grant Award
7.3.1. Analysis by Amount Awarded
7.3.2. Analysis by Administering Institute Centre
7.3.3. Analysis by Support Period
7.3.4. Analysis by Administering Institute Centre and Support Period
7.3.5. Analysis by Type of Grant Application
7.3.6. Analysis by Purpose of Grant
7.3.7. Analysis by Purpose of Grant and Amount Awarded
7.3.8. Analysis by Activity Code
7.3.9. Analysis by Study Section Involved
7.3.10. Analysis by Type of Organization
7.3.11. Word Cloud: Emerging Focus Areas
7.3.12. Most Popular Departments: Analysis by Number of Grants
7.3.13. Prominent Program Officers: Analysis by Number of Grants
7.3.14. Popular Recipient Organizations: Analysis by Number of Grants
7.3.15. Popular Recipient Organizations: Analysis by Amount Awarded
7.3.16. Analysis of Recipient Organizations located in the US

8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. RNA Sequencing: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Application Year
8.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
8.3.4. Analysis by Geography
8.3.5. Analysis by CPC Symbols
8.3.6. Analysis by Focus Area
8.3.7. Analysis by Type of Applicant
8.3.8. Leading Players: Analysis by Number of Patents
8.3.9. Leading Individual Assignees: Analysis by Number of Patents

8.4. RNA Sequencing: Patent Benchmarking Analysis
8.4.1. Analysis by Patent Characteristics

8.5. RNA sequencing: Patent Valuation Analysis
8.6. Leading Patents: Analysis by Number of Citations

9. PORTER’S FIVE FORCES ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Assumptions
9.3. Key Parameters
9.3.1. Threats of New Entrants
9.3.2. Power of Customers
9.3.3. Power of RNA Sequencing Service Providers
9.3.4. Threats of Substitute Services
9.3.5. Rivalry Among Existing Competitors

9.4. Concluding Remarks

10. CASE STUDY: NGS LIBRARY PREPARATION KITS
10.1. Chapter Overview
10.2. NGS Library Preparation Kits: Overall Market Landscape
10.2.1. Analysis by Type of Platform
10.2.2. Analysis by Amount of Sample
10.2.3. Analysis by Turnaround Time
10.2.4. Analysis by Storage Temperature
10.2.5. Analysis by Type of Sequencing
10.2.6. Analysis by Kit Components
10.2.7. Analysis by Type of Sample

10.3. NGS Library Preparation Kits: Developer Landscape
10.3.1. Analysis by Year of Establishment
10.3.2. Analysis by Company Size
10.3.3. Analysis by Region of Headquarters

11. INVESTMENT POTENTIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Profit Potential of Commonly used RNA Sequencing Platforms
11.2.1. iSeq: Likely Profit Potential
11.2.2. MiSeq: Likely Profit Potential
11.2.3. NextSeq 550 Series: Likely Profit Potential
11.2.4. NextSeq 1000: Likely Profit Potential
11.2.5. NextSeq 1000: Likely Profit Potential
11.2.6. Sequel: Likely Profit Potential
11.2.7. Sequel II: Likely Profit Potential
11.2.8. Sequel IIe: Likely Profit Potential
11.4. Payback Evaluation Matrix

11.3. Conclusion

12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global RNA Sequencing Services Market, 2022-2035
12.3.1. RNA Sequencing Services Market, 2022-2035: Distribution by Type of Sequencing Method
12.3.1.1. RNA Sequencing Services Market for Next Generation Sequencing Methods, 2022-2035
12.3.1.2. RNA Sequencing Services Market for Other Methods, 2022-2035

12.3.2. RNA Sequencing Services Market, 2022-2035: Distribution by Type of Application Area
12.3.2.1. RNA Sequencing Services Market for Research Purposes, 2022-2035
12.3.2.2. RNA Sequencing Services Market for Diagnostic Purposes, 2022-2035

12.3.3. RNA Sequencing Services Market, 2022-2035: Distribution by Type of End User Industry
12.3.3.1. RNA Sequencing Services Market for Academic and Research Industry, 2022-2035
12.3.3.2. RNA Sequencing Services Market for Clinics and Hospitals, 2022-2035
12.3.3.3. RNA Sequencing Services Market for Pharmaceutical Industry, 2022-2035
12.3.3.4. RNA Sequencing Services Market for Other Users, 2022-2035

12.3.4. RNA Sequencing Services Market, 2022-2035: Distribution by Key Geographical Regions
12.3.4.1. RNA Sequencing Services Market in North America, 2022-2035
12.3.4.2. RNA Sequencing Services Market in Europe, 2022-2035
12.3.4.3. RNA Sequencing Services Market in Asia-Pacific, 2022-2035
12.3.4.4. RNA Sequencing Services Market in Latin America, 2022-2035
12.3.4.5. RNA Sequencing Services Market in Middle East and North Africa, 2022-2035

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Key Steps Involved in RNA Sequencing
Figure 4.1 RNA Sequencing Service Providers: Distribution by Year of Establishment
Figure 4.2 RNA Sequencing Service Providers: Distribution by Company Size
Figure 4.3 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Region Wise)
Figure 4.4 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Country Wise)
Figure 4.5 RNA Sequencing Service Providers: Distribution by Company Size and Region of Headquarters
Figure 4.6 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s) Offered
Figure 4.7 RNA Sequencing Service Providers: Distribution by Platform
Figure 4.8 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s) and Type of Platform
Figure 4.9 RNA Sequencing Service Providers: Distribution by Turnaround Time
Figure 4.10 RNA Sequencing Service Providers: Distribution by Type of Sample
Figure 4.11 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Services(s) and Type of Sample
Figure 4.12 RNA Sequencing Service Providers: Distribution by Amount of Sample (in mg)
Figure 4.13 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Services(s) and Amount of Sample
Figure 5.1 Company Competitiveness Analysis: RNA Sequencing Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: RNA Sequencing Service Providers in Europe
Figure 5.3 Company Competitiveness Analysis: RNA Sequencing Service Providers in Asia-Pacific
Figure 7.1 Grant Analysis: Cumulative Year-Wise Trend, 2017-2022
Figure 7.2 Grant Analysis: Distribution by Amount Awarded (USD Million)
Figure 7.3 Grant Analysis: Distribution by Administering Institute Centre
Figure 7.4 Grant Analysis: Distribution by Support Period
Figure 7.5 Grant Analysis: Distribution by Administering Institute Centre and Support Period
Figure 7.6 Grant Analysis: Distribution by Type of Grant Application
Figure 7.7 Grant Analysis: Distribution by Purpose of Grant Award
Figure 7.8 Grant Analysis: Distribution of Amount Awarded by Purpose of Grant (USD Million)
Figure 7.9 Grant Analysis: Distribution by Activity Code
Figure 7.10 Grant Analysis: Distribution by Study Section Involved
Figure 7.11 Grant Analysis: Distribution by Type of Organization
Figure 7.12 Most Popular Departments: Distribution by Number of Grants
Figure 7.13 Word Cloud: Emerging Focus Areas
Figure 7.14 Prominent Program Officers: Distribution by Number of Grants
Figure 7.15 Popular Recipient Organizations: Distribution by Number of Grants
Figure 7.16 Popular Recipient Organization: Distribution by Amount Awarded (USD Million)
Figure 7.17 Grant Analysis: Distribution of Recipient Organizations located in US
Figure 8.1 Patent Analysis: Distribution by Type of Patent
Figure 8.2 Patent Analysis: Cumulative Distribution by Publication Year, 2018-2022
Figure 8.3 Patent Analysis: Cumulative Distribution by Application Year, Pre-2016 - 2022
Figure 8.4 Patent Analysis: Distribution by Annual Number of Granted Patents and Patent Applications, 2018-2022
Figure 8.5 Patent Analysis: Distribution by Geography
Figure 8.6 Patent Analysis: Distribution by CPC Symbols
Figure 8.7 Word Cloud: Emerging Focus Areas
Figure 8.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 8.9 Leading Industry Players: Distribution by Number of Patents
Figure 8.10 Leading Non-Industry Players: Distribution by Number of Patents
Figure 8.11 Patent Analysis: Leading Individual Assignees
Figure 8.12 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Symbols)
Figure 8.13 Patent Analysis: Distribution by Patent Age
Figure 8.14 Patent Valuation Analysis
Figure 9.1 Porter’s Five Forces: Key Parameters
Figure 9.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 10.1 NGS Library Preparation Kits: Distribution by Type of Platform
Figure 10.2 NGS Library Preparation Kits: Distribution by Amount of Sample
Figure 10.3 NGS Library Preparation Kits: Distribution by Turnaround Time
Figure 10.4 NGS Library Preparation Kits: Distribution by Storage Temperature
Figure 10.5 NGS Library Preparation Kits: Distribution by Type of Sequencing
Figure 10.6 NGS Library Preparation Kits: Distribution by Kit Components
Figure 10.7 NGS Library Preparation Kits: Distribution by Type of Sample
Figure 10.8 NGS Library Preparation Kit Providers: Distribution by Year of Establishment
Figure 10.9 NGS Library Preparation Kit Providers: Distribution by Company Size
Figure 10.10 NGS Library Preparation Kit Providers: Distribution by Location of Headquarters
Figure 11.1 Likely Profit Potential of iSeq platform
Figure 11.2 Likely Profit Potential of MiSeq platform
Figure 11.3 Likely Profit Potential of NextSeq 550 Series platform
Figure 11.4 Likely Profit Potential of NextSeq 1000 platform
Figure 11.5 Likely Profit Potential of NextSeq 2000 platform
Figure 11.6 Likely Profit Potential of Sequel platform
Figure 11.7 Likely Profit Potential of Sequel II platform
Figure 11.8 Likely Profit Potential of Sequel IIe platform
Figure 11.9 Payback Evaluation Matrix
Figure 12.1 Global RNA Sequencing Services Market, 2022-2035 (USD Billion)
Figure 12.2 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Sequencing Method
Figure 12.3 RNA Sequencing Services Market for Next Generation Sequencing Method, 2022-2035 (USD Billion)
Figure 12.4 RNA Sequencing Services Market for Other Method, 2022-2035 (USD Billion)
Figure 12.5 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Application
Figure 12.6 RNA Sequencing Services Market for Research Purposes, 2022-2035 (USD Billion)
Figure 12.7 RNA Sequencing Services Market for Diagnostic Purposes, 2022-2035 (USD Billion)
Figure 12.8 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of End User
Figure 12.9 RNA Sequencing Services Market for Academic and Research Industry, 2022-2035 (USD Billion)
Figure 12.10 RNA Sequencing Services Market for Clinics and Hospitals, 2022-2035 (USD Billion)
Figure 12.11 RNA Sequencing Services Market for Pharmaceutical Industry, 2022-2035 (USD Billion)
Figure 12.12 RNA Sequencing Services Market for Other Users, 2022-2035 (USD Billion)
Figure 12.13 RNA Sequencing Services Market, 2022 and 2035: Distribution by Key Geographical Regions
Figure 12.14 RNA Sequencing Services Market in North America, 2022-2035 (USD Billion)
Figure 12.15 RNA Sequencing Services Market in Europe, 2022-2035 (USD Billion)
Figure 12.16 RNA Sequencing Services Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 12.17 RNA Sequencing Services Market in Latin America, 2022-2035 (USD Billion)
Figure 12.18 RNA Sequencing Services Market in Middle East and North Africa, 2022-2035 (USD Billion)

List Of Tables

Table 4.1 List of RNA Sequencing Service Providers
Table 4.2 RNA Sequencing Service Providers: Information on Type of RNA Sequencing Service(s), Type of Platform, and Turnaround time
Table 4.3 RNA Sequencing Service Providers: Information on Type of RNA Sequencing Service(s), Type of Sample, and Amount of Sample
Table 6.1 Admera Health: Company Overview
Table 6.2 Admera Health: RNA Sequencing Service Portfolio
Table 6.3 Biogazelle: Company Overview
Table 6.4 Biogazelle: RNA Sequencing Service Portfolio
Table 6.5 CD Genomics: Company Overview
Table 6.6 CD Genomics: RNA Sequencing Service Portfolio
Table 6.7 Creative Biogene: Company Overview
Table 6.8 Creative Biogene: RNA Sequencing Service Portfolio
Table 6.9 IGA Technology: Company Overview
Table 6.10 IGA Technology: RNA Sequencing Service Portfolio
Table 6.11 LC Sciences: Company Overview
Table 6.12 LC Sciences: RNA Sequencing Service Portfolio
Table 6.13 Lexogen: Company Overview
Table 6.14 Lexogen: RNA Sequencing Service Portfolio
Table 6.15 Lexogen: Recent Developments and Future Outlook
Table 6.16 Novogene: Company Overview
Table 6.17 Novogene: RNA Sequencing Service Portfolio
Table 6.18 Novogene: Recent Developments and Future Outlook
Table 6.19 Otogenetics: Company Overview
Table 6.20 Otogenetics: RNA Sequencing Service Portfolio
Table 6.21 Yaazh Xenomic: Company Overview
Table 6.22 Yaazh Xenomics: RNA Sequencing Service Portfolio
Table 8.1 Patent Analysis: Most Popular CPC Symbols
Table 8.2 Patent Analysis: List of Top CPC Symbols
Table 8.3 Patent Analysis: Summary of Benchmarking Analysis
Table 8.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 8.5 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 8.6 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 11.1 Investment Analysis and Likely Profit Potential: Cost Consideration
Table 11.2 Investment Analysis and Likely Profit Potential: Revenue Consideration
Table 11.3 Investment Analysis and Likely Profit Potential: Minimum Sales Required for iSeq 100
Table 11.4 Investment Analysis and Likely Profit Potential: Minimum Sales Required for MiSeq
Table 11.5 Investment Analysis and Likely Profit Potential: Minimum Sales Required for NextSeq 550
Table 11.6 Investment Analysis and Likely Profit Potential: Minimum Sales Required for NextSeq 1000
Table 11.7 Investment Analysis and Likely Profit Potential: Minimum Sales Required for NextSeq 2000
Table 11.8 Investment Analysis and Likely Profit Potential: Minimum Sales Required for Sequel
Table 11.9 Investment Analysis and Likely Profit Potential: Minimum Sales Required for Sequel II
Table 11.10 Investment Analysis and Likely Profit Potential: Minimum Sales Required for Sequel IIe
Table 11.11 Investment Analysis and Likely Profit Potential: Payback Evaluation Matrix
Table 15.1 RNA Sequencing Service Providers: Distribution by Year of Establishment
Table 15.2 RNA Sequencing Service Providers: Distribution by Company Size
Table 15.3 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Region-wise)
Table 15.4 RNA Sequencing Service Providers: Distribution by Location of Headquarters (Country-wise)
Table 15.5 RNA Sequencing Service Providers: Distribution by Company Size and Region of Headquarters
Table 15.6 RNA Sequencing Service Providers: Distribution by Type of RNA Sequencing Service(s)
Table 15.7 RNA Sequencing Service Providers: Distribution by Turnaround Time
Table 15.8 RNA Sequencing Service Providers: Distribution by Type of Sample
Table 15.9 RNA Sequencing Service Providers: Distribution by Amount of Sample (in mg)
Table 15.10 Grant Analysis: Cumulative Year-Wise Trend, 2018-2022
Table 15.11 Grant Analysis: Distribution by Amount Awarded (USD Million)
Table 15.12 Grant Analysis: Distribution by Administering Institute Centre
Table 15.13 Grant Analysis: Distribution by Support Period
Table 15.14 Grant Analysis: Distribution by Type of Grant Application
Table 15.15 Grant Analysis: Distribution of Amount Awarded by Purpose of Grant Award (USD Million)
Table 15.16 Grant Analysis: Distribution by Purpose of Grant Award
Table 15.17 Grant Analysis: Distribution by Activity Code
Table 15.18 Grant Analysis: Distribution by Study Section Involved
Table 15.19 Grant Analysis: Distribution by Type of Organization
Table 15.20 Most Popular Departments: Distribution by Number of Grants
Table 15.21 Prominent Program Officers: Distribution by Number of Grants
Table 15.22 Popular Recipient Organizations: Distribution by Number of Grants
Table 15.23 Popular Recipient Organizations: Distribution by Amount of Grant
Table 15.24 Grant Analysis: Distribution of Recipient Organizations located in US
Table 15.25 Patent Analysis: Distribution by Type of Patent
Table 15.26 Patent Analysis: Cumulative Distribution by Publication Year, 2018-2022
Table 15.27 Patent Analysis: Cumulative Distribution by Application Year, Pre-2016 - 2022
Table 15.28 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patents Applications, 2018-2022
Table 15.29 Patent Analysis: Distribution by Geography
Table 15.30 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Table 15.31 Leading Industry Players: Distribution by Number of Patents
Table 15.32 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.33 Patent Analysis: Leading Individual Assignees
Table 15.34 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 15.35 NGS Library Preparation Kits: Distribution by Type of Platform
Table 15.36 NGS Library Preparation Kits: Distribution by Amount of Sample
Table 15.37 NGS Library Preparation Kits: Distribution by Turnaround Time
Table 15.38 NGS Library Preparation Kits: Distribution by Storage Temperature
Table 15.39 NGS Library Preparation Kits: Distribution by Type of Sequencing
Table 15.40 NGS Library Preparation Kits: Distribution by Kit Components
Table 15.41 NGS Library Preparation Kits: Distribution by Type of Sample
Table 15.42 NGS Library Preparation Kits Providers: Distribution by Year of Establishment
Table 15.43 NGS Library Preparation Kits Providers: Distribution by Company Size
Table 15.44 NGS Library Preparation Kits Providers: Distribution by Location of Headquarters
Table 15.45 Likely Profit Potential of iSeq platform
Table 15.46 Likely Profit Potential of MiSeq platform
Table 15.47 Likely Profit Potential of NextSeq 550 Series platform
Table 15.48 Likely Profit Potential of NextSeq 1000 platform
Table 15.49 Likely Profit Potential of NextSeq 2000 platform
Table 15.50 Likely Profit Potential of Sequel platform
Table 15.51 Likely Profit Potential of Sequel II platform
Table 15.52 Likely Profit Potential of Sequel IIe platform
Table 15.53 Global RNA Sequencing Services Market, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.54 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Sequencing Method
Table 15.55 RNA Sequencing Services Market for Next Generation Sequencing Method, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.56 RNA Sequencing Services Market for Other Methods, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.57 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of Application
Table 15.58 RNA Sequencing Services Market for Research Purposes, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.59 RNA Sequencing Services Market for Diagnostic Purposes, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.60 RNA Sequencing Services Market, 2022 and 2035: Distribution by Type of End User
Table 15.61 RNA Sequencing Services Market for Academic and Research Industry, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.62 RNA Sequencing Services Market for Clinics and Hospitals, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.63 RNA Sequencing Services Market for Pharmaceutical Industry, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.64 RNA Sequencing Services Market for Other Users, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.65 RNA Sequencing Services Market, 2022 and 2035: Distribution by Key Geographical Regions
Table 15.66 RNA Sequencing Services Market in North America, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.67 RNA Sequencing Services Market in Europe, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.68 RNA Sequencing Services Market in Asia-Pacific, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.69 RNA Sequencing Services Market in Latin America, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.70 RNA Sequencing Services Market in Middle East and North Africa, Conservative, Base, and Optimistic Scenarios, 2022-2035 (USD Bllion)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report:

1. Abclonal
2. Active Motif
3. Admera Health
4. Agendia
5. Agilent Technologies
6. AgriGenome Labs
7. Allen Institute
8. Almac
9. Applied Biological Materials
10. Arraystar
11. Australian Genome Research Facility (AGRF)
12. Back Bay Life Science Advisors 
13. BaseClear
14. BGI
15. Bioarray Genetics
16. BioCat
17. BioChain
18. BioDynami
19. Biogazelle (acquired by CellCarta)
20. Biokart India 
21. Bioneer
22. Bio-Rad
23. Bioserve Biotechnologies (a subsidiary of Reprocell Company)
24. Brigham and Women's Hospital
25. C2i Genomics
26. CD Genomics
27. CeGaT
28. Celemics
29. Cellecta
30. Clevergene Biocorp
31. Columbia University Health Sciences
32. Creative Biogene
33. Creative Biolabs
34. Creative BioMart
35. CureVac
36. DiaCarta
37. Diagenode (acquired by Hologic)
38. Diagnomics
39. DNA Link
40. DNAVision
41. Duke Center for Genomic and Computational Biology
42. Eclipse Bioinnovations
43. Enzo Life Sciences
44. Eremid Research Services
45. Eurofins Genomics
46. Fasteris
47. Firalis
48. Fluidigm
49. Frontage Laboratories
50. Garvan Institute of Medical Research
51. GB HealthWatch
52. GCC Biotech
53. GENEWIZ (acquired by Azenta Life Sciences)
54. Genome Quebec
55. GenomeScan
56. Genome Technology Access Center (a part of Washington University)
57. Genomix4Life
58. Genotypic Technology
59. GenXPro
60. Grail
61. Harvard Medical School
62. Icahn School of Medicine
63. IGA Technology Services
64. Illumina
65. IntegraGen (acquired by OncoDNA)
66. Integrated DNA Technologies
67. Isogen Life Science
68. Johns Hopkins University
69. Koninklijke Philips
70. LC Sciences
71. Lexogen
72. Loop Genomics
73. Macrogen
74. Massachusetts General Hospital
75. Massachusetts Institute of Technology (MIT)
76. Mayo Clinic
77. MedGenome
78. Memorial Sloan Kettering Cancer Center
79. Messenger Biopharma
80. MGI
81. Microsynth
82. Molecular Research (MR DNA)
83. myGenomics
84. New England Biolabs (NEB)
85. Norgen Biotek
86. Novogene
87. Nucleome Informatics
88. Omega Bioservices
89. Otogenetics
90. Oxford Nanopore Technologies
91. Pacific Biosciences (PacBio)
92. PerkinElmer
93. PhalanxBio (a subsidiary of Phalanx Biotech)
94. Psomagen
95. Q2 Solutions
96. QIAGEN
97. Quick Biology
98. RealSeq Biosciences
99. RefGen Biotechnology
100. RNA Society
101. Roche
102. SeqMatic
103. Source BioScience
104. SRM Institute of Science and Technology
105. Stanford University
106. Swift Biosciences (acquired by Integrated DNA Technologies)
107. System Biosciences (SBI)
108. Takara Bio
109. TAmiRNA
110. Tecan
111. Thermo Fisher Scientific
112. TIANGEN Biotech
113. TriLink BioTechnologies
114. Ultima Genomics
115. University of California
116. University of Pennsylvania
117. Vazyme Biotech
118. Xcelris Genomics
119. Yaazh Xenomics
120. Yale University
121. YouSeq
122. Zymo Research